/

Batteries & E-Mobility

/

Octapharma

Octapharma

Octapharma

Verified Nov 2026

Batteries & E-Mobility

·

Switzerland flag

Lachen, Schwyz

·

Since 1983

Octapharma is a privately held Swiss pharmaceutical company founded in 1983 and headquartered in Lachen, Switzerland. With 10,000–50,000 employees, it is privately owned plasma fractionator, operating in approximately 120 countries. The company develops and manufactures human protein medicines for hematology, immunotherapy, and critical care, sourcing plasma through over 180 donation centers across the US and Europe. In 2026, Octapharma announced a $1.5 billion critical care manufacturing facility in Rock Hill, South Carolina.

Octapharma

Verified Nov 2026

AT A GLANCE

Founded

1983

Headquarters

Switzerland flag

Lachen, Schwyz

Employees

10,000-50,000

Ownership

Octapharma at a glance

Revenue

$1-5B

Est. band

Employees

10,000-50,000

Founded

1983

Headquarters

Lachen, Schwyz

Import activity

8

Industries

Automotive

Electric Vehicles

Medical

Renewable Energy

Industrial Equipment

Sourcing and import activity

From US customs bill-of-lading records

US sea imports

8

Named foreign suppliers

3

Top origins

Mexico

Chart of the supplier's US import shipment volume trend over time

Shared foreign counterparties do not establish that these companies buy from Octapharma.

What this tells a buyer

Octapharma recorded 8 customs shipments with origins in Mexico, supplied by affiliated entities including Octapharma De and Octapharma S A De C V.

The company produces medicines under GMP standards from human plasma and human cell lines, with R&D and manufacturing facilities across multiple countries including Switzerland, Austria, France, and the United States.

Octapharma serves healthcare systems, hospitals, and clinics across approximately 120 countries and operates over 180 plasma donation centers to source plasma for its therapeutic products.

Source: US customs bill-of-lading records and public filings · Last verified Nov 13, 2026

STABILITY SIGNALS

Established & active

43 years in operation (founded 1983).

8 US import shipments on record.

Overview

Octapharma is a privately held Swiss pharmaceutical company founded in 1983 and headquartered in Lachen, Switzerland. With 10,000–50,000 employees, it is privately owned plasma fractionator, operating in approximately 120 countries. The company develops and manufactures human protein medicines for hematology, immunotherapy, and critical care, sourcing plasma through over 180 donation centers across the US and Europe. In 2026, Octapharma announced a $1.5 billion critical care manufacturing facility in Rock Hill, South Carolina.

At a glance

Attribute

Detail

Founded

1983

Headquarters

Lachen, Schwyz

Employees

10,000-50,000

Revenue

$1-5B (estimated)

Primary capability

Batteries & E-Mobility

What Octapharma makes

The company produces medicines under GMP standards from human plasma and human cell lines, with R&D and manufacturing facilities across multiple countries including Switzerland, Austria, France, and the United States.

Products and capabilities described on the company's own site include Transmission (source: octapharma.com).

Trade and customs footprint

Octapharma recorded 8 customs shipments with origins in Mexico, supplied by affiliated entities including Octapharma De and Octapharma S A De C V. US customs bill-of-lading records list 8 inbound shipments across 3 foreign suppliers, with top origins including Mexico.

Latest developments

Facilities

Octapharma is headquartered in Lachen, Schwyz. Public sources also reference these locations:

Company details

Octapharma serves healthcare systems, hospitals, and clinics across approximately 120 countries and operates over 180 plasma donation centers to source plasma for its therapeutic products. Octapharma was founded in 1983, has an estimated 10,000-50,000 employees, and is headquartered in Lachen, Schwyz. On the LightSource stability read it is rated "Established & active": 43 years in operation (founded 1983). 8 US import shipments on record.

Frequently asked questions

What does Octapharma make?

Octapharma is a privately held Swiss pharmaceutical company founded in 1983 and headquartered in Lachen, Switzerland. With 10,000–50,000 employees, it is privately owned plasma fractionator, operating in approximately 120 countries. The company develops and manufactures human protein medicines for hematology, immunotherapy, and critical care, sourcing plasma through over 180 donation centers across the US and Europe. In 2026, Octapharma announced a $1.5 billion critical care manufacturing facility in Rock Hill, South Carolina.

Where is Octapharma headquartered?

Octapharma is headquartered in Lachen, Schwyz (2 Seidenstrasse, Lachen, Schwyz, 8853).

When was Octapharma founded?

Octapharma was founded in 1983.

How big is Octapharma?

Octapharma has an estimated 10,000-50,000 employees, with revenue in the $1-5B range (estimated).

Does Octapharma import from overseas suppliers?

US customs bill-of-lading records show 8 inbound shipments for Octapharma, with top origins including Mexico.

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Lachen, Schwyz (HQ)Headquarters · Switzerland
Lachen, Schwyz (HQ)2 Seidenstrasse, Lachen, Schwyz, 8853, SwitzerlandHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.